Ledger.Open graph →
SEC Form D · filed August 7, 2025

Coeptis Therapeutics Holdings, Inc

Offering
$5.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEXFORD, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Philippe M. Deschamps · Wexford, PADirectorBrian Cogley · Wexford, PAExecTara M. Desilva · Wexford, PADirectorPhilippe M. Deschamps · Wexford, PADirectorTara M. Desilva · Wexford, PADirectorChristopher Cochran · Wexford, PADirectorGene M. Salkind · Wexford, PADirectorBrian Cogley · Wexford, PAExecDaniel Yerace · Wexford, PADirectorGene M. Salkind · Wexford, PADirectorChristopher Calise · New York, NYDirectorDavid Mehalick · Wexford, PAExec · DirectorDavid Mehalick · Wexford, PAExec · DirectorChristopher Calise · New York, NYDirectorDaniel Yerace · Wexford, PADirectorChristopher Cochran · Wexford, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗